Cullinan Therapeutics Insider Trades
NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $1.39M
- Sales
- 28 · $2.51M
- Shares bought / sold
- 165.67K / 165.91K
- Net activity
- Net selling $1.1 million
Cullinan Therapeutics insider activity
Over the last 12 months, Cullinan Therapeutics insiders reported 40 transactions on SEC Form 4: 1 open-market purchase and 28 sales. Insiders bought $1.4 million and sold $2.5 million worth of stock, for net insider selling of $1.1 million. The largest seller was Michaelson Jennifer, with $1.6 million in reported sales.
The most recent filing shows Michaelson Jennifer (Chief Scientific Officer) reporting a transaction in 4,000 shares at $4.30 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CGEM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CGEM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 8,000 | $172.56K | Form 4 |
| Sep 8, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 4,000 | $17.20K | Form 4 |
| Aug 13, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 30,000 | $607.80K | Form 4 |
| Aug 13, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 30,000 | $129.00K | Form 4 |
| Jul 6, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 8,000 | $142.56K | Form 4 |
| Jul 6, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 4,000 | $17.20K | Form 4 |
| Jun 30, 2026 | Fenton Mary KayChief Financial Officer | Award | 1,541 | $13.25K | Form 4 |
| Jun 30, 2026 | SUMER JACQUELYN LChief Legal Officer | Award | 2,470 | $21.24K | Form 4 |
| May 5, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 200 | $3.12K | Form 4 |
| May 5, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 7,800 | $113.88K | Form 4 |
| May 5, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 4,000 | $17.20K | Form 4 |
| Mar 5, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 8,000 | $125.44K | Form 4 |
| Mar 5, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 4,000 | $17.20K | Form 4 |
| Feb 25, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 1,780 | $25.17K | Form 4 |
| Feb 24, 2026 | SUMER JACQUELYN LChief Legal Officer | Sale | 3,601 | $52.11K | Form 4 |
| Feb 24, 2026 | Jones Jeffrey AlanChief Medical Officer | Sale | 4,582 | $66.30K | Form 4 |
| Feb 24, 2026 | AHMED NADIMPresident and CEO | Sale | 13,515 | $195.56K | Form 4 |
| Feb 24, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 3,601 | $52.11K | Form 4 |
| Feb 23, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 1,752 | $24.51K | Form 4 |
| Feb 20, 2026 | SUMER JACQUELYN LChief Legal Officer | Sale | 3,742 | $50.97K | Form 4 |
| Feb 20, 2026 | AHMED NADIMPresident and CEO | Sale | 16,381 | $223.11K | Form 4 |
| Feb 20, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 8,000 | $114.40K | Form 4 |
| Feb 20, 2026 | Michaelson JenniferChief Scientific Officer | Option exercise | 8,000 | $34.40K | Form 4 |
| Feb 20, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 3,742 | $50.97K | Form 4 |
| Feb 20, 2026 | Fenton Mary KayChief Financial Officer | Sale | 4,398 | $59.90K | Form 4 |
| Feb 20, 2026 | Jones Jeffrey AlanChief Medical Officer | Sale | 4,982 | $67.85K | Form 4 |
| Feb 18, 2026 | Michaelson JenniferChief Scientific Officer | Award | 57,500 | — | Form 4 |
| Feb 18, 2026 | Fenton Mary KayChief Financial Officer | Award | 68,750 | — | Form 4 |
| Feb 12, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 416 | $5.00K | Form 4 |
| Jan 22, 2026 | Michaelson JenniferChief Scientific Officer | Sale | 4,000 | $49.20K | Form 4 |
| Dec 31, 2025 | Fenton Mary KayChief Financial Officer | Award | 27 | $175.23 | Form 4 |
| Dec 23, 2025 | AHMED NADIMPresident and CEO | Sale | 9,922 | $99.32K | Form 4 |
| Dec 19, 2025 | Michaelson JenniferChief Scientific Officer | Sale | 1,345 | $13.46K | Form 4 |
| Dec 18, 2025 | Michaelson JenniferChief Scientific Officer | Sale | 2,898 | $28.02K | Form 4 |
| Dec 18, 2025 | Jones Jeffrey AlanChief Medical Officer | Sale | 4,632 | $44.79K | Form 4 |
| Dec 18, 2025 | SUMER JACQUELYN LChief Legal Officer | Sale | 3,480 | $33.65K | Form 4 |
| Dec 15, 2025 | Michaelson JenniferChief Scientific Officer | Sale | 995 | $11.84K | Form 4 |
| Dec 12, 2025 | Michaelson JenniferChief Scientific Officer | Sale | 2,148 | $26.59K | Form 4 |
| Nov 24, 2025 | Michaelson JenniferChief Scientific Officer | Sale | 4,000 | $49.20K | Form 4 |
| Oct 28, 2025 | Lynx1 Capital Management LP & Nichols Weston10% Owner | Buy | 165,667 | $1.39M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4